In the afternoon of October 2, 2019, Dr. Ming-Wei Wang (Director, The National Center for Drug Screening/Chinese National Compound Library and Dean, School of Pharmacy, Fudan University) met with Dr. Hui Li (Vice President of Business Development and General Manager of China Operations, Sorrento Therapeutics, Inc., NASDAQ: SRNE) at San Diego, California, U.S.A. They conducted a productive discussion relative to forging research collaborations in the area of antibody-drug conjugate technologies.